SCHEMBL29566960

SCHEMBL29566960

Cc1ccccc1Oc1cc(C2CCCCC2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 10/20 0.39
▸ HTR7 P34969 10/20 0.39
▸ DRD2 P14416 4/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ TSHR P16473 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ NLRP3 Q96P20 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ HTR2A P28223 3/20 0.33
▸ SLC8A1 P32418 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309834 1.00 HTR1A (0.39) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL26807637 0.99 HTR1A (0.40) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL29566649 0.88 HTR1A (0.42) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL26807354 0.88 HTR1A (0.42) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL26807484 0.87 HTR1A (0.43) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL29566828 0.86 BRD4 (0.36) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL24310339 0.86 BRD4 (0.36) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL24309983 0.86 HTR1A (0.39) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL26810543 0.85 HTR1A (0.39) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL24310322 0.84 HTR1A (0.40) HTR1AHTR7DRD2HTR6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback